Study links ADHD to a measurable brain activity pattern, with early signs it may be modifiable

byHebrew University of JerusalemStudy design. Credit:NeuroImage: Clinical(2025). DOI: 10.1016/j.nicl.2025.103923A new study suggests that children with ADHD may exhibit a distinctive, measurable patte

Neurology March 07,2026

Study links ADHD to a measurable brain activity pattern, with early signs it may be modifiable

byHebrew University of JerusalemStudy design. Credit:NeuroImage: Clinical(2025). DOI: 10.1016/j.nicl.2025.103923A new study suggests that children with ADHD may exhibit a distinctive, measurable patte

Neurology March 07,2026

Lab platform models human organs to test cancer drug toxicity without animals

byUniversity of GenevaDifferentiated hepatic cells growing in a flask re-gain the appearance of cells present in liver. Credit: FAMOL, UNIGEOvercoming acquired treatment resistance is one of the major

Hematology&Oncology March 07,2026

Lab platform models human organs to test cancer drug toxicity without animals

byUniversity of GenevaDifferentiated hepatic cells growing in a flask re-gain the appearance of cells present in liver. Credit: FAMOL, UNIGEOvercoming acquired treatment resistance is one of the major

Hematology&Oncology March 07,2026

Health care consolidation and rising costs

by Julie ApplebyCredit: Unsplash/CC0 Public DomainIn a recent "Meet the Press" appearance, Sen. James Lankford, R-Okla., joined a growing number of Republicans who are speaking out against O

Wellness March 07,2026

Health care consolidation and rising costs

by Julie ApplebyCredit: Unsplash/CC0 Public DomainIn a recent "Meet the Press" appearance, Sen. James Lankford, R-Okla., joined a growing number of Republicans who are speaking out against O

Wellness March 07,2026

Guideline-concordant care rate in seniors is approximately 60% after positive lung cancer screen

by Elana GotkineAmong persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant care is 59.7% overall, according to a studypublishedonline D

Family Medicine March 07,2026

Guideline-concordant care rate in seniors is approximately 60% after positive lung cancer screen

by Elana GotkineAmong persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant care is 59.7% overall, according to a studypublishedonline D

Family Medicine March 07,2026

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe

Hematology&Oncology March 07,2026

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe

Hematology&Oncology March 07,2026

Stress intensifies pain and makes it harder to regulate emotions in cases of depression and fibromyalgia

by Torsten Lauer,Central Institute of Mental HealthSchematic of EMA and fMRI neurofeedback method. Credit:Pain(2025). DOI: 10.1097/j.pain.0000000000003800A new study led by the Central Institute of Me

Psychiatry & Mental Health March 06,2026

Stress intensifies pain and makes it harder to regulate emotions in cases of depression and fibromyalgia

by Torsten Lauer,Central Institute of Mental HealthSchematic of EMA and fMRI neurofeedback method. Credit:Pain(2025). DOI: 10.1097/j.pain.0000000000003800A new study led by the Central Institute of Me

Psychiatry & Mental Health March 06,2026

Study examines oligodendrocyte dynamics throughout the progression of multiple sclerosis

byIngrid Fadelli, Medical XpressStormy weather: oligodendrocyte dynamics in a mouse model of multiple sclerosis. Castelo-Branco research group, Karolinska Institutet. Credit: Bastien Hervé and Lilian

Neurology March 06,2026

Study examines oligodendrocyte dynamics throughout the progression of multiple sclerosis

byIngrid Fadelli, Medical XpressStormy weather: oligodendrocyte dynamics in a mouse model of multiple sclerosis. Castelo-Branco research group, Karolinska Institutet. Credit: Bastien Hervé and Lilian

Neurology March 06,2026

Glycosylation enzyme selectivity in mouse kidneys shows promise for future disease research

by Institute for Glyco-core Research (iGCORE)Selective modification of substrate by GnT-V in polarized kidney tissue in mice. Credit:iScience(2025). DOI: 10.1016/j.isci.2025.113894Glycans are importan

Family Medicine March 06,2026

Glycosylation enzyme selectivity in mouse kidneys shows promise for future disease research

by Institute for Glyco-core Research (iGCORE)Selective modification of substrate by GnT-V in polarized kidney tissue in mice. Credit:iScience(2025). DOI: 10.1016/j.isci.2025.113894Glycans are importan

Family Medicine March 06,2026

Half of US adults resolve to start a new diet in 2026

by Physicians Committee for Responsible MedicineCredit: Unsplash/CC0 Public DomainNearly half of U.S. adults say starting a new diet is one of their New Year's resolutions, according to a new Phys

Wellness March 06,2026

Half of US adults resolve to start a new diet in 2026

by Physicians Committee for Responsible MedicineCredit: Unsplash/CC0 Public DomainNearly half of U.S. adults say starting a new diet is one of their New Year's resolutions, according to a new Phys

Wellness March 06,2026

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

by Josephine Wright, Susan Woods,The ConversationCredit: CC0 Public DomainBacteria are rapidly emerging as anew classof "living medicines" used to kill cancer cells.We're still a long wa

Hematology&Oncology March 06,2026

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

by Josephine Wright, Susan Woods,The ConversationCredit: CC0 Public DomainBacteria are rapidly emerging as anew classof "living medicines" used to kill cancer cells.We're still a long wa

Hematology&Oncology March 06,2026